HomeBUSINESS
BUSINESS

Eisai’s Oral Solid Dose Facility Completed in China
(Jan.12.2018)

Eisai said on January 11 that its China subsidiary has completed the construction of a new oral solid dose manufacturing facility in its new Suzhou plant, aiming to beef up production for Methycobal (mecobalamin), Aricept (donepezil), and Pariet (rabeprazole) bound for the China market ...
(LOG IN FOR FULL STORY)